Cargando…
Simplifying the drug provocation test in non‐immediate hypersensitivity reactions to amoxicillin in children: The experience of a tertiary care allergy unit
BACKGROUND: Mild non‐immediate reactions (NIR) to beta‐lactams (βLs) are the most common manifestation of adverse drug reactions in children, and the drug provocation test (DPT) remains the gold standard for diagnosis. However, there are still controversies about the protocol that should be used, es...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328376/ https://www.ncbi.nlm.nih.gov/pubmed/35754120 http://dx.doi.org/10.1111/pai.13809 |
_version_ | 1784757707441438720 |
---|---|
author | Liccioli, Giulia Giovannini, Mattia Caubet, Jean‐Christoph Barni, Simona Sarti, Lucrezia Parronchi, Paola Capone, Manuela Tomei, Leonardo Mori, Francesca |
author_facet | Liccioli, Giulia Giovannini, Mattia Caubet, Jean‐Christoph Barni, Simona Sarti, Lucrezia Parronchi, Paola Capone, Manuela Tomei, Leonardo Mori, Francesca |
author_sort | Liccioli, Giulia |
collection | PubMed |
description | BACKGROUND: Mild non‐immediate reactions (NIR) to beta‐lactams (βLs) are the most common manifestation of adverse drug reactions in children, and the drug provocation test (DPT) remains the gold standard for diagnosis. However, there are still controversies about the protocol that should be used, especially regarding the administration of doses and the DPT length. OBJECTIVE: This study aimed to evaluate a pediatric population with a history of mild NIR to amoxicillin (AMX) or to amoxicillin‐clavulanic acid (AMX/CL) who underwent a diagnostic workup including a DPT with the culprit drug, to understand if a graded DPT or, instead, a single full dose could be the most appropriate way of administration in clinical practice. METHODS: The data of children were retrospectively analyzed for a 5‐year period, with demographic and clinical characteristics collected. We reported the allergy workup and the results of the DPT performed with the administration of incremental doses and a prolonged DPT at home for a total of 5 days. RESULTS: Three hundred fifty‐four patients were included. Overall, 23/354 (6.5%) DPTs were positive: 11/23 patients showed a reaction after 2–8 h after the last dose on the 1st or 2nd day (1 reacted 30 min after the last dose), 1/23 reacted with urticaria 30 min after the first dose, 11/23 reacted at home on the 5th day of the DPT. CONCLUSION: This paper indirectly suggests that a single therapeutic dose administered on the 1st day of a DPT could be safe in the diagnostic workup of mild NIR to AMX/CL. Moreover, this could be less time‐consuming as patients would spend less time in the hospital, also considering the public health restrictions imposed during the COVID‐19 pandemic. |
format | Online Article Text |
id | pubmed-9328376 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93283762022-07-30 Simplifying the drug provocation test in non‐immediate hypersensitivity reactions to amoxicillin in children: The experience of a tertiary care allergy unit Liccioli, Giulia Giovannini, Mattia Caubet, Jean‐Christoph Barni, Simona Sarti, Lucrezia Parronchi, Paola Capone, Manuela Tomei, Leonardo Mori, Francesca Pediatr Allergy Immunol Original Articles BACKGROUND: Mild non‐immediate reactions (NIR) to beta‐lactams (βLs) are the most common manifestation of adverse drug reactions in children, and the drug provocation test (DPT) remains the gold standard for diagnosis. However, there are still controversies about the protocol that should be used, especially regarding the administration of doses and the DPT length. OBJECTIVE: This study aimed to evaluate a pediatric population with a history of mild NIR to amoxicillin (AMX) or to amoxicillin‐clavulanic acid (AMX/CL) who underwent a diagnostic workup including a DPT with the culprit drug, to understand if a graded DPT or, instead, a single full dose could be the most appropriate way of administration in clinical practice. METHODS: The data of children were retrospectively analyzed for a 5‐year period, with demographic and clinical characteristics collected. We reported the allergy workup and the results of the DPT performed with the administration of incremental doses and a prolonged DPT at home for a total of 5 days. RESULTS: Three hundred fifty‐four patients were included. Overall, 23/354 (6.5%) DPTs were positive: 11/23 patients showed a reaction after 2–8 h after the last dose on the 1st or 2nd day (1 reacted 30 min after the last dose), 1/23 reacted with urticaria 30 min after the first dose, 11/23 reacted at home on the 5th day of the DPT. CONCLUSION: This paper indirectly suggests that a single therapeutic dose administered on the 1st day of a DPT could be safe in the diagnostic workup of mild NIR to AMX/CL. Moreover, this could be less time‐consuming as patients would spend less time in the hospital, also considering the public health restrictions imposed during the COVID‐19 pandemic. John Wiley and Sons Inc. 2022-06-03 2022-06 /pmc/articles/PMC9328376/ /pubmed/35754120 http://dx.doi.org/10.1111/pai.13809 Text en © 2022 The Authors. Pediatric Allergy and Immunology published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Original Articles Liccioli, Giulia Giovannini, Mattia Caubet, Jean‐Christoph Barni, Simona Sarti, Lucrezia Parronchi, Paola Capone, Manuela Tomei, Leonardo Mori, Francesca Simplifying the drug provocation test in non‐immediate hypersensitivity reactions to amoxicillin in children: The experience of a tertiary care allergy unit |
title | Simplifying the drug provocation test in non‐immediate hypersensitivity reactions to amoxicillin in children: The experience of a tertiary care allergy unit |
title_full | Simplifying the drug provocation test in non‐immediate hypersensitivity reactions to amoxicillin in children: The experience of a tertiary care allergy unit |
title_fullStr | Simplifying the drug provocation test in non‐immediate hypersensitivity reactions to amoxicillin in children: The experience of a tertiary care allergy unit |
title_full_unstemmed | Simplifying the drug provocation test in non‐immediate hypersensitivity reactions to amoxicillin in children: The experience of a tertiary care allergy unit |
title_short | Simplifying the drug provocation test in non‐immediate hypersensitivity reactions to amoxicillin in children: The experience of a tertiary care allergy unit |
title_sort | simplifying the drug provocation test in non‐immediate hypersensitivity reactions to amoxicillin in children: the experience of a tertiary care allergy unit |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328376/ https://www.ncbi.nlm.nih.gov/pubmed/35754120 http://dx.doi.org/10.1111/pai.13809 |
work_keys_str_mv | AT liccioligiulia simplifyingthedrugprovocationtestinnonimmediatehypersensitivityreactionstoamoxicillininchildrentheexperienceofatertiarycareallergyunit AT giovanninimattia simplifyingthedrugprovocationtestinnonimmediatehypersensitivityreactionstoamoxicillininchildrentheexperienceofatertiarycareallergyunit AT caubetjeanchristoph simplifyingthedrugprovocationtestinnonimmediatehypersensitivityreactionstoamoxicillininchildrentheexperienceofatertiarycareallergyunit AT barnisimona simplifyingthedrugprovocationtestinnonimmediatehypersensitivityreactionstoamoxicillininchildrentheexperienceofatertiarycareallergyunit AT sartilucrezia simplifyingthedrugprovocationtestinnonimmediatehypersensitivityreactionstoamoxicillininchildrentheexperienceofatertiarycareallergyunit AT parronchipaola simplifyingthedrugprovocationtestinnonimmediatehypersensitivityreactionstoamoxicillininchildrentheexperienceofatertiarycareallergyunit AT caponemanuela simplifyingthedrugprovocationtestinnonimmediatehypersensitivityreactionstoamoxicillininchildrentheexperienceofatertiarycareallergyunit AT tomeileonardo simplifyingthedrugprovocationtestinnonimmediatehypersensitivityreactionstoamoxicillininchildrentheexperienceofatertiarycareallergyunit AT morifrancesca simplifyingthedrugprovocationtestinnonimmediatehypersensitivityreactionstoamoxicillininchildrentheexperienceofatertiarycareallergyunit |